BNP Paribas Financial Markets’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.73K | Sell |
|
|||||
|
2025
Q2 | $8.23K | Sell |
|
|||||
|
2025
Q1 | $41.1K | Buy |
|
|||||
|
2024
Q4 | $14.6K | Sell |
|
|||||
|
2024
Q3 | $50K | Buy |
|
|||||
|
2024
Q2 | $31.3K | Sell |
|
|||||
|
2024
Q1 | $143K | Buy |
|
|||||
|
2023
Q4 | $49.8K | Sell |
|
|||||
|
2023
Q3 | $131K | Buy |
|
|||||
|
2023
Q2 | $57.6K | Buy |
|
|||||
|
2023
Q1 | $45.1K | Buy |
|
|||||
|
2022
Q4 | $15.7K | Sell |
|
|||||
|
2022
Q3 | $37.1K | Sell |
|
|||||
|
2022
Q2 | $30K | Sell |
|
|||||
|
2022
Q1 | $223K | Buy |
|
|||||
|
2021
Q4 | $407K | Buy |
|
|||||
|
2021
Q3 | $73.3K | Buy |
|
|||||
|
2021
Q2 | $12.7K | Sell |
|
|||||
|
2021
Q1 | $39.9K | Sell |
|
|||||
|
2020
Q4 | $26.9K | Sell |
|
|||||
|
2020
Q3 | $13.7K | Buy |
|
|||||
|
2020
Q2 | $5.73K | Sell |
|
|||||
|
2020
Q1 | $26.8K | Buy |
|
|||||
|
2019
Q4 | $23.8K | Sell |
|
|||||
|
2019
Q3 | $23.2K | Buy |
|
|||||
|
2019
Q2 | $35.8K | Sell |
|
|||||
|
2019
Q1 | $55.2K | Buy |
|
|||||
|
2018
Q4 | $6.34K | Sell |
|
|||||
|
2018
Q3 | $27.9K | Buy |
|
|||||
|
2018
Q2 | $29.2K | Sell |
|
|||||
|
2018
Q1 | $80.4K | Buy |
|
|||||
|
2017
Q4 | $90.9K | Buy |
|
|||||
|
2017
Q3 | $63.1K | Sell |
|
|||||
|
2017
Q2 | $89.6K | Buy |
|
|||||
|
2017
Q1 | $13K | Sell |
|
|||||
|
2016
Q4 | $19K | Sell |
|
|||||
|
2016
Q3 | $63.6K | Buy |
|
|||||
|
2016
Q2 | $23.6K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $120K | Buy |
|
|||||
|
2015
Q3 | $95K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $5.42K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $19K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.61K | Sell |
|
|||||
|
2013
Q4 | $6.25K | Sell |
|
|||||
|
2013
Q3 | $151K | Sell |
|
|||||
|
2013
Q2 | $166K | Buy |
|